The FDA has reprimanded Dexcel and its affiliate Edenbridge Pharmaceuticals for "false or misleading" promotional claims regarding its brand-name drug Hemady.
The Latest
Kris Green was promoted to vice president of human resources at Jones Memorial Hospital in Wellsville, N.Y.
In November 2024, Salt Lake City-based University of Utah Health and Chicago-based CommonSpirit formed a clinical partnership to give patients at five CommonSpirit hospitals access to physicians and providers at the academic health system. Four months later, the parties are…
Mark Klosterman, president and CEO of Sidney, Ohio-based Wilson Health, will retire April 11.
In this episode, Scott Becker speaks with Dr. Joseph Cacchione, CEO of Jefferson Health and Thomas Jefferson University. Dr. Cacchione discusses the system’s growth, the challenges facing healthcare—including reimbursement cuts and financial headwinds—and the importance of integrating care delivery with…
Interventions to reduce antibiotic use have found success in two level IV neonatal intensive care units, according to research published in Pediatrics.
In the race to optimize healthcare operations, AI agents have emerged as the shiny new weapon in the revenue cycle arsenal. But are these digital workers the salvation of strained billing departments or simply hype? The reality, as with most…
Trent Green, CEO of One Medical since 2023, is leaving the primary care company for a new role at National Research Corp., a healthcare analytics and services provider.
Caryn Karff was named administrative director of radiology for Fox Chase Cancer Center, Temple University Hospital-Jeanes Campus and Temple Health-Chestnut Hill Hospital, all based in Philadelphia, according to a March 4 system news release.
Cambridge, Mass.-based Beth Israel Lahey Health recorded a $2.7 million operating loss (-0.1% operating margin) in the first quarter of 2025, an improvement from an operating loss of $44.8 million (-2.1% margin) in the same period in 2024, according to…